Philogen SpA (CHIX:PHILM) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:PHILM Philogen SpA CHIX:PHILM
61 GF Score
Price €15.20
GF Value €136.19
! 4 Warning Signs
View Full Analysis

What is Philogen SpA Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

CHIX:PHILM
61GF Score
Philogen SpA CHIX:PHILM
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Philogen SpA (CHIX:PHILM) Overvalued in 2026?

Based on GuruFocus' analysis, Philogen SpA stock appears to be undervalued. The current stock price of €15.20 is trading 88.8% below its estimated GF Value™ of €136.19.

Key valuation signals for CHIX:PHILM:

  • Dividends Received:
  • GF Value™: €136.19 vs. price of €15.20 (88.8% below fair value)
  • GF Score™: 61/100 with 4 warning signs

No single metric tells the full story. See the CHIX:PHILM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Philogen SpA Business Description

Other Exchanges PHIL:Italy78Q:Germany
Address Piazza La Lizza No. 7, Siena, ITA, 53100
Philogen SpA is a biotechnology company engaged in the research and development of antibody-based therapeutics for the treatment of cancer and chronic inflammatory diseases. The company's pipeline includes products such as Nidlegy, Fibromun, Darleukin, and Dekavil, targeting oncology and other serious conditions. Geographically, the company operates in the European Union, Switzerland, and the United States of America.
61GF Score

Get the complete analysis for CHIX:PHILM

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€15.20
Price
€136.19
GF Value